These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 10357727

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.
    Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M.
    Lancet; 1998 Jul 18; 352(9123):167-72. PubMed ID: 9683204
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.
    Finer N, James WP, Kopelman PG, Lean ME, Williams G.
    Int J Obes Relat Metab Disord; 2000 Mar 18; 24(3):306-13. PubMed ID: 10757623
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group.
    Rössner S, Sjöström L, Noack R, Meinders AE, Noseda G.
    Obes Res; 2000 Jan 18; 8(1):49-61. PubMed ID: 10678259
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial.
    Smith SR, Stenlof KS, Greenway FL, McHutchison J, Schwartz SM, Dev VB, Berk ES, Kapikian R.
    Obesity (Silver Spring); 2011 Sep 18; 19(9):1796-803. PubMed ID: 21720429
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity.
    Krempf M, Louvet JP, Allanic H, Miloradovich T, Joubert JM, Attali JR.
    Int J Obes Relat Metab Disord; 2003 May 18; 27(5):591-7. PubMed ID: 12704403
    [Abstract] [Full Text] [Related]

  • 17. A one-year trial to assess the value of orlistat in the management of obesity.
    James WP, Avenell A, Broom J, Whitehead J.
    Int J Obes Relat Metab Disord; 1997 Jun 18; 21 Suppl 3():S24-30. PubMed ID: 9225173
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influences of fat restriction and lipase inhibition on gastric emptying in obesity.
    Mathus-Vliegen EM, van Ierland-van Leeuwen ML, Bennink RJ.
    Int J Obes (Lond); 2006 Aug 18; 30(8):1203-10. PubMed ID: 16462818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.